Sitagliptin Phosphate Intermedia Impuritas CAS 769195-268 Puritas >99.0% (HPLC)

Description:

Methyl 3-Oxo-4-(2,4,5-Trifluorophenyl)butanoate

CAS: 769195-268

Puritas: >99.0% (HPLC)

Aspectus: Alba ad Off-White pulveris

Intermedia / Impuritas de Sitagliptin Phosphate

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Methyl 3-Oxo-4-(2,4,5-Trifluorophenyl)butanoate (CAS: 769195-26-8) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	Methyl 3-Oxo-4-(2,4,5-Trifluorophenyl)butanoate
Synonyma	Sitagliptin Impurity 17;2,4,5-Trifluoro-β-Oxo-Benzenebutanoicum Acidum Methyl Ester
CAS Number	769195-268
CATTUS Number	RF2656
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C11H9F3O3
M. Pondus	246.18
Liquescens punctum	40.0~41.0℃
Ferveret	273.3±35.0℃
Density	1.330±0.06 g/cm3
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White pulveris
Puritas / Analysis Methodus	>99.0% (HPLC)
Damnum in Siccatio	<1.00%
una immunditia	<0.50%
Totalis immunditias	<1.00%
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Intermedia / Impuritas de Sitagliptin Phosphate

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

Methyl 3-Oxo-4-(2,4,5-Trifluorophenyl) butanoate (CAS: 769195-26-8) utilis synthetica media in synthesi Sitagliptin (CAS: 486460-32-6), Sitagliptin Phosphate (CAS. : 654671-78-0).Sitagliptin phosphate dipeptidylum peptidase est Ⅳ (DDP-4) inhibitor medicamentorum genus a societate Germanica Merck evoluta ac primum in Cibus US et medicamentum Administration approbavit ad tractationem generis diabete II diabete, novum medicamentum antidiabeticum, proprium corporis emendare. facultatem reducendi gradus altos sanguinis glucosi, et incrementa relative naturaliter incretina occurrentia, inhibendo activitatem huius enzyme, inter gradus peptidis glucagon-similes 1 et peptidium insulinotropicum glucosum dependens, ita pancreas excitando ad productionem insulinam emendandam et glucosam sistendam. productio in hepate, et tandem reducere effectum clinicum sanguinis glucose conducit.